Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.67 |
| ▸ | ESR1 | P03372 | 13/20 | 0.64 |
| ▸ | ESR2 | Q92731 | 13/20 | 0.64 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23734330 | 0.93 | TAAR1 (0.59) | TAAR1SLC6A2ESR1ESR2CYP2C9 | |
| SCHEMBL28452098 | 0.91 | TAAR1 (0.57) | TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL7526486 | 0.88 | TAAR1 (0.59) | TAAR1SLC6A2ESR1ESR2SLC7A5 | |
| SCHEMBL358059 | 0.88 | TAAR1 (0.59) | TAAR1SLC6A2ESR1ESR2SLC7A5 | |
| SCHEMBL8056894 | 0.88 | TAAR1 (0.59) | TAAR1SLC6A2ESR1ESR2SLC7A5 | |
| SCHEMBL13165991 | 0.88 | TAAR1 (0.59) | TAAR1SLC6A2ESR1ESR2SLC7A5 | |
| SCHEMBL358607 | 0.88 | TAAR1 (0.59) | TAAR1SLC6A2ESR1ESR2SLC7A5 | |
| SCHEMBL443017 | 0.88 | TAAR1 (0.59) | TAAR1SLC6A2ESR1ESR2SLC7A5 | |
| SCHEMBL9188158 | 0.86 | TAAR1 (0.57) | TAAR1SLC6A2ESR1ESR2SLC7A5 | |
| SCHEMBL10662257 | 0.86 | TAAR1 (0.57) | TAAR1SLC6A2ESR1ESR2SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3235850-B1 | POLYCARBONATE COPOLYMER AND PREPARATION METHOD THEREFOR | SAMYANG CORP (KR) | 2020-02-12 | — | — | EP | claimed |
| US-10081708-B2 | Polycarbonate copolymer and preparation method therefor | SAMYANG CORPORATION (KR) | 2018-09-25 | — | — | US | claimed |
| US-20180162994-A1 | Polycarbonate Copolymer And Preparation Method Therefor | SAMYANG CORPORATION (KR) | 2018-06-14 | — | — | US | claimed |
| EP-3235850-A1 | POLYCARBONATE COPOLYMER AND PREPARATION METHOD THEREFOR | Samyang Corporation (KR) | 2017-10-25 | — | — | EP | claimed |
| WO-2024117864-A1 | POLYCARBONATE COPOLYMER COMPRISING UNITS DERIVED FROM ANHYDROSUGAR ALCOHOL, AROMATIC DIOL, AND HYDROXY-TERMINATED SILOXANE, METHOD FOR PRODUCING SAME, AND MOLDED ARTICLE COMPRISING SAME | 주식회사 삼양사 | 2024-06-06 | — | — | WO | disclosed |
| EP-4368659-A1 | HYDROXYPHENYL-TERMINATED POLYSILOXANE, POLYSILOXANE-POLYCARBONATE COPOLYMER HAVING EXCELLENT TRANSPARENCY AND IMPROVED FLAME RETARDANCY AND COMPRISING SAME AS REPEATING UNIT, AND METHOD FOR PREPARING SAME COPOLYMER | Samyang Corporation (KR) | 2024-05-15 | — | — | EP | disclosed |
| EP-4269501-A1 | POLYCARBONATE RESIN COMPOSITION FOR 3D PRINTING HAVING EXCELLENT SHAPE RETENTION ABILITY AND INTERFACIAL ADHESION, AND PELLET AND FILAMENT FOR 3D PRINTING COMPRISING SAME | Samyang Corporation (KR) | 2023-11-01 | — | — | EP | disclosed |
| US-20230295381-A1 | POLYSILOXANE-POLYCARBONATE COPOLYMER USING HYDROXY-TERMINATED POLYSILOXANE MIXTURE, AND METHOD FOR PRODUCING SAME | SAMYANG CORPORATION (KR) | 2023-09-21 | — | — | US | disclosed |
| EP-4141046-A1 | POLYSILOXANE-POLYCARBONATE COPOLYMER USING HYDROXY-TERMINATED POLYSILOXANE MIXTURE, AND METHOD FOR PRODUCING SAME | Samyang Corporation (KR) | 2023-03-01 | — | — | EP | disclosed |
| US-20230002534-A1 | POLYESTER-POLYCARBONATE COPOLYMER AND METHOD FOR PRODUCING SAME | SAMYANG CORPORATION (KR) | 2023-01-05 | — | — | US | disclosed |
| WO-2021215838-A1 | POLYSILOXANE-POLYCARBONATE COPOLYMER USING HYDROXY-TERMINATED POLYSILOXANE MIXTURE, AND METHOD FOR PRODUCING SAME | 주식회사 삼양사 (KR) | 2021-10-28 | — | — | WO | disclosed |
| EP-3838987-A1 | POLYCARBONATE RESIN COMPOSITION FOR 3D PRINTING AND 3D PRINTING FILAMENT COMPRISING SAME | Samyang Corporation (KR) | 2021-06-23 | — | — | EP | disclosed |
| EP-2554571-A2 | HYDROXY-TERMINATED SILOXANE, POLYSILOXANE-POLYCARBONATE COPOLYMER, AND PREPARATION METHOD THEREOF | Samyang Corporation (KR) | 2013-02-06 | — | — | EP | disclosed |
| US-20120309922-A1 | HYDROXY-TERMINATED SILOXANE, POLYSILOXANE-POLYCARBONATE COPOLYMER, AND PREPARATION METHOD THEREOF | SAMYANG CORPORATION (KR) | 2012-12-06 | — | — | US | disclosed |
| WO-2010030787-A1 | ESTROGEN RECEPTOR LIGANDS | RADIUS HEALTH, INC. (US) | 2010-03-18 | — | — | WO | disclosed |
| WO-2010030787-A1 | ESTROGEN RECEPTOR LIGANDS | RADIUS HEALTH, INC. (US) | 2010-03-18 | — | — | WO | disclosed |
| US-6753404-B2 | PHOSGENATION; ALIPHATIC DIACID SALT AND CARBONATE PRECURSOR FORMS ALIPHATE DIACID CHLORIDE; FORMING DIHYDRIC PHENOL SALT; OLIGMERIZATION; MOLECULAR WEIGHT CONTROL; CONDENSATION POLYMERIZATION | SAMYANG CORPORATION (KR) | 2004-06-22 | — | — | US | disclosed |
| US-20030018159-A1 | Continuous process for the preparation of copolycarbonate resins | SAMYANG CORPORATION (KR) | 2003-01-23 | — | — | US | disclosed |
| WO-2001049772-A1 | A CONTINUOUS PROCESS FOR THE PREPARATION OF COPOLYCARBONATE RESINS | SAMYANG CORPORATION (KR) | 2001-07-12 | — | — | WO | disclosed |
| EP-0305325-A2 | Co-advanced epoxy resins from polyglycidyl ethers of polyhydric phenols and diglycidyl ethers of di-secondary alcohols | CIBA-GEIGY AG (CH) | 1989-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309922-A1 | HYDROXY-TERMINATED SILOXANE, POLYSILOXANE-POLYCARBONATE COPOLYMER, AND PREPARATION METHOD THEREOF | SEM1, P4HA1, SULT1A1 | TAAR1 2600/4885SLC6A2 4720/4885ESR1 678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.